Rankings
▼
Calendar
AMRN Q2 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$53M
+16.4% YoY
Gross Profit
$40M
75.6% margin
Operating Income
-$32M
-61.4% margin
Net Income
-$34M
-65.0% margin
EPS (Diluted)
$-2.33
QoQ Revenue Growth
+19.9%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$204M
Total Liabilities
$251M
Stockholders' Equity
-$47M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$53M
$45M
+16.4%
Gross Profit
$40M
$34M
+17.6%
Operating Income
-$32M
-$11M
-183.4%
Net Income
-$34M
-$14M
-150.9%
Revenue Segments
Product
$53M
100%
License
$106,000
0%
← FY 2018
All Quarters
Q3 2018 →